Entamoeba histolytica: An update

Current Opinion in Infectious Diseases

Volumn 16, Issue 5, 2003, Pages 479-485

  Stauffer, William ^a,b   Ravdin, Jonathan I ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b REGIONS HOSPITAL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Amoebiasis; Amoebic abscess; Amoebic colitis; Entamoeba histolytica

Indexed keywords

FURAZOLIDONE; METRONIDAZOLE; PAROMOMYCIN; PROTOZOAL VACCINE; TINIDAZOLE;

AMEBIASIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIARRHEA; DRUG COST; DRUG EFFECT; ENTAMOEBA HISTOLYTICA; EPIDEMIOLOGICAL DATA; HOST RESISTANCE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PROTOZOAL GENETICS; REVIEW;

ANIMALS; ANTIPROTOZOAL AGENTS; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; FURAZOLIDONE; HUMANS; PAROMOMYCIN; VACCINES;

EID: 0142012093     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200310000-00016     Document Type: Review

References (67)

1. Petri WA Jr, Haque R, Mann BJ. The bittersweet interface of parasite and host: Lectin-carbohydrate interactions during human invasion by the parasite Entemoeba histolyca. Annu Rev Microbiol 2002; 56:39-64. This is a thorough and concise review of the galactose/GalNAc lectin and its role in pathogenesis and host immunity.
2. World Health Organization (WHO). Weekly Epidemiol Rec 1997; 72:97-99.
3. Pan American Health Organization (PAHO). Epidemiol Bull 1997; 18:13-14.
4. World Health Organization (WHO). Bull WHO 1997; 75:291-292.
5. Diamond LS, Clark CG. A redescription of Entamoeba histolytica Shaudinn, 1903 (amended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol 1993; 40(3):340-344.
6. Abd-Alla MD, Jackson TF, Gathiram V, et al. Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces. J Clin Microbiol 1993; 31:2845-2850.
7. Gathiram V, Jackson TF. Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population. Lancet 1985; 1:719-721.
8. Gatharim V, Jackson TF. A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. S Afr Med J 1987; 72:669-672.
9. Blessmann J, Van Linh P, Nu PA, et al. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. Am J Trop Med Hyg 2002; 66:578-583. This is one of the first epidemiologic reports estimating the prevalence of amoebic liver abscess in a high prevalence population.
10. Haque R, Duggal P, Ali IM, et al. Innate and acquired resistance to amebiasis in Bangladeshi children. J Infect Dis 2002; 86:547-552. This large, well-conducted, study helped to elucidate the host factors that are protective and detrimental in the development of Entamoeba histolytica.
11. Abd-Alla M, Wahib A, Ravdin JI. Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhoea in Cairo, Egypt. Trop Med Intl Health 2002; 7:1-6.
12. Gatti S, Swierczynski G, Robinson F, et al. Amebic infections due to the Entmoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador. Am J Trop Med Hyg 2002; 67:123-127.
13. Petri WA, Singh U. Diagnosis and management of amebiasis. Clin Infect Dis 1999; 29:1117-1125.
14. Stauffer WM, Kamat D, Walker PF. Screening of international immigrants, refugees, and adoptees. Prim Care Clin Office Pract 2002; 29:879-905.
15. Barwick R, Uzicanin A, Lareau S, et al. Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998. Am J Trop Med Hyg 2002; 67:623-631.
16. Braga LL, Gomes ML, DaSilva MW, et al. Household epidemiology of Entamoeba histolytica infection in an urban community in northeastern Brazil. Am J Trop Med Hyg 2001; 65:268-271.
17. Ali IKM, Hossain MB, Roy S, et al. Entameba moshkovskii infections in children in Bangladesh. Emerg Infect Dis 1993; 9:580-584.
18. Stauffer WM, Kamat D, Maroushek S. Medical screening of international children. Clin Pediatr (Phila) (in press).
19. Pillai DR, Keystone JS, Sheppard DC, et al. Entamoeba histolytica and Entamoeba dispar epidemiology and comparison of diagnostic methods in a setting of nonendemicity. Clin Infect Dis 1999; 29:1315-1318.
20. Ravdin JI, Guerrant RL. The role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest 1981; 68:1305-1313.
21. Petri WA, Smith RD, Schlesinger PH, Ravdin JI. Isolation of the galactose-binding lectin which mediates the in vitro adherence of Enfamoeba hisfolytica. J Clin Invest 1987; 80:1238-1244.
22. Chadee K, Petri WA, Innes DJ, Ravdin JI. Rat and human colonic mucins bind to and inhibit the adherence lectin of Entamoeba histolytica. J Clin Invest 1987; 80:1245-1254.
23. Eichinger D. A role for a galactose lectin and its ligands during encystment of Entamoeba. J Eukarot Microbiol 2001; 48:17-21.
24. Guerrant RL, Brush J, Ravdin JI, et al. The interaction between Entamoeba histolytica and human polymorphonuclear leukocytes. J Infect Dis 1981; 143:83-93.
25. Salata RA, Pearson RD, Ravdin JI. Interaction of human leukocytes with Entamoeba histolytica: killing of virulent amebae by the activated macrophage. J Clin Invest 1985; 76:491-499.
26. Salata RA, Martinez-Palomo A, Murphy CF, et al. Patients treated for amebic liver abscess develop a cell-mediated immune response effective in vitro against Entamoeba histolytica. J Immunol 1986; 136:2633-2639.
27. Ravdin JI, Stanley P, Murphy CF, Petri WA Jr. Characterization of cell surface carbohydrate receptors for Entamoeba histolytica adherence lectin. Infect Immun 1989; 57:2179-2186.
28. Leippe M, Ebel S, Schoenberger OL, et al. Pore-forming peptide of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A 1991; 88:7659-7663.
29. Ravdin JI, Moreau F, Sullivan JA, et al. The relationship of free intracellular calcium ions to the cytolytic activity of Entamoeba histolytica. Infect Immun 1988; 56:1505-1512.
30. Que X, Reed SL. The role of extraacellular cysteine proteinases in pathogenesis of Entamoeba histolytica invasion. Parasitol Today 1997; 13:190-194.
31. Bruchhaus I, Nowak N, Loftus BJ, et al. The intestinal protozoan parasite Entamoeba histolytica contains a multitude of twenty cysteine protease genes of which only a small subset is expressed during in-vitro cultivation. EMBO Workshop on Pathogenesis of Amoebiasis: from Genomics to Disease. Institut Pasteur. Paris France. May 19-May 21 2003:7.
32. Huston CD, Houpt ER, Mann BJ, et al. Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cell Micrabiol 2000; 2:617-625.
33. Ragland BD, Ashley LS, Vaux DL, et al. Entamoeba histolytica: target cells killed by trophozoites undergo DNA fragmentation which is not blocked by Bcl-2. Exp Parasitol 1994; 79:460-467.
34. Yan L, Stanley SL Jr. Blockade of caspases inhibits amebic liver abscess formation in a mouse model of disease. Infect Immun 2001; 69:7911-7914.
35. Huston CD, Boettner DR, Miller-Sim V, et al. Apoptotic killing and phagocytosis of host cells by the parasite Entamoeba histolytica. Infect Immun 2003; 71:964-972. An important mechanism by which Entamoeba histolytica minimizes inflammation is described.
36. Haque R, Huston CD, Hughes M, et al. Current concepts: Amebiasis. N Engl J Med 2003; 348:1565-1573. This is an excellent review of amoebiasis.
37. Mai Z, Ghosh S, Frisardi M, et al. Hsp60 is targeted to a cryptic mitochondrion derived organelle ("cryton") in the microaerophilic protozoan parasite Entamoeba histolytica. Mol Cell Biol 1999; 19:2198-2205.
38. Tovar J, Fischer A, Clark CG. The mitosome, a novel organelle related to mitochondria in the amitochondriate parasite Entameba histolytica. Mol Micrabiol 1999; 32:1012-1021.
39. Gonzalez E, Rico G, Mendoza G, et al. Calreticulin-like molecule in trophozoites of Entamoeba histolytica HM1:IMSS (SWISSPROT: ACCESSION P83003). Am J Trop Med Hyg 2002; 67:636-639.
40. Loftus BJ. Sequencing and initial analysis of the Entamoeba histolytica genome and comparative genomics of related Entamoeba species. EMBO Workshop on Pathogenesis of Amoebiasis: from Genomics to Disease. Institut Pasteur. Paris France. May 19-May 21 2003:3.
41. Hall N. Entamoeba Sequencing at The Sanger Institute. EMBO Workshop on Pathogenesis of Amoebiasis: from Genomics to Disease. Institut Pasteur. Paris France. May 19-May 21 2003:4.
42. Mann BJ. Enfamoeba histolytica genome project: an update. Trends Parasitol 2002; 18:147-148.
43. Ramos MA, Sanchez-Lopez R, Olvera F, et al. Entamoeba histolytica genomic organization: identification, structure, and phylogenetic relationship of 2 serine-threonine protein kinases. Exp Parasitol 2002; 100:135-139.
44. Haghighi A, Kobayashi S, Takeuchi T, et al. Genetic polymorphism among E. histolytica isolates. J Clin Microbiol 2002; 40:4981-4090.
45. Rigothier MC, Khun H, Tavares P, et al. Fate of Entamoeba histolytica during the establishment of amoebic liver abscess analyzed by quantitative radio-imaging and histology. Infect Immun 2002; 70:3208-3215.
46. Arellano J, Perez-Rodriguez M, Lopez-Osuna M, et al. Increased frequency of HLA-DR3 and complotype SCO1 in Mexican mestizo children with amoebic abscess of the liver. Parasite Immunol 1996; 18:491-498.
47. Braga LL, Ninomiya H, McCoy JJ, et al. Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J Clin Invest 1992; 90:1131-1137.
48. Reed SL, Ember JA, Herdman DS, et al. The extracellular neutral cysteine proteinases of Entamoeba histolytica degrades anaphylaztoxins C3a and C5a. J Immunol 1995; 155:266-274.
49. Sanchez-Guillen MC, Perez-Fuentes R, Salgado-Rosas H, et al. Differentiation of Entamoeba histolytica/Entamoeba dispar by PCR and their correlation with humoral and cellular immunity in individuals with clinical variants of amoebiasis. Am J Trop Med Hyg 2002; 66:731-737.
50. Salata RA, Ahmed P, Ravdin JI. Chemo-attractant activity of Entamoeba histolytica for human polymorphonuclear neutrophils. J Parasitol 1989; 75:644-646.
51. Olivos A, Tello E, Nequiz M, et al. Entamoeba histolytica: cysteine proteinase activity is required for survival of the parasite in experimental acute amoebic liver abscesses in hamsters. EMBO Workshop on Pathogenesis of Amoebiasis: from Genomics to Disease. Institut Pasteur. Paris France. May 19-May 21 2003:28.
52. Beving DE, Soong CJ, Ravdin JI. Oral immunization with a recombinant cysteine-rich section of Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity. Infect Immun 1996; 64:1473-1476.
53. Mann BJ, Chung CY, Dodson JM, et al. Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesion map to the cysteine-rich extracellular domain of the 170-kilodalton subunit. Infect Imm 1993; 61:1772-1778.
54. Abd Alla MD, Jackson TF, Tannich E, et al. Identification of humans IgG and IgA lectin epitopes associated with immunity to intestinal infection by Entamoeba species. EMBO Workshop on Pathogenesis of Amoebiasis: from Genomics to Disease. Institut Pasteur. Paris France. May 19-May 21 2003:31.
55. Petri WA Jr, Jackson TFGH, Gathiram V, et al. Pathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin. Infec Immun. 1990; 29:2234-2239.
56. Pillai DR, Wan PS, Yau YC, et al. The cysteine-rich region of the Entamoeba histolytica adherence lectin (170-kilodalton subunit) is sufficient for high-affinity Gal/GalNAc-specific binding in vitro. Infect Immun 1999; 67:3836-3841.
57. Beck DL, Tanyuksel M, Mackey AJ, et al. Entamoeba histolytica: sequence conservation of the Gal/GalNAc lectin from clinical isolates. Exp Parasitol 2002; 101:157-163. This important study found that the cysteine rich site of the heavy chain of the lectin, a primary vaccine target, is well conserved.
58. Miller-Sims VC, Petri WA Jr. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica. Curr Opin Immunol 2002; 14:549-552. This is a concise review of the current status and need for vaccine development for Entamoeba histolytica.
59. Mann BJ, Burkholder BV, Lockhart LA. Protection in a gerbil model of amoebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica. Vaccine 1997; 15:659-663.
60. Lotter H, Russmann H, Tannich E. Oral vaccination with recombinant Yersinia expressing hybrid type III proteins protects gerbils from amebic liver abscess. EMBO Workshop on Pathogenesis of Amoebiasis: from Genomics to Disease. Institut Pasteur. Paris France. May 19-May 21 2003:60.
61. Gaucher D, Chadee K. Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin based DNA vaccine. Vaccine 2002; 20:3244-3253.
62. Haque R, Mollah NU, Ali IKM, et al. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol 2000; 38:3235-3239.
63. Abd-Alla MD, Jackson TF, Reddy S, et al. Diagnosis of invasive amebiasis by enzyme-linked immunosorbent assay of saliva to detect amebic lectin antigen and anti-lectin immunoglobulin G antibodies. J Clin Microbiol 2000; 38:2344-2347.
64. Abd-Alla MD, Wahib AA, Ravdin JI. Comparison of antigen-capture ELISA to stool-culture methods for the detection of asymptomatic Entamoeba species infection in Kafer Daoud, Egypt. Am J Trop Med Hyg 2002; 62:579-582.
65. Sanuki J, Nakano K, Tokoro M, et al. Purification and identification of major soluble 40-kDa antigenic protein from Entamoeba histolytica: its application for serodiagnosis of asymptomatic amebiasis. Parasitol Int 2001; 50:73-80.
66. Blessmann J, Buss H, Phuong A, et al. Real-time PCR for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in fecal samples. J Clin Microbiol 2002; 40:4413-4417.
67. Blessmann J, Tannich E. Treatment of asymptomatic intestinal Entamoeba histolytica infection. N Engl J Med 2002; 347:1384.